Predictive Oncology Inc. financial data

Symbol
POAI on Nasdaq
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Location
91 43 Rd Street, Suite 110, Pittsburgh, PA
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Precision Therapeutics Inc. (to 6/4/2019), Skyline Medical Inc. (to 2/6/2018), BioDrain Medical, Inc. (to 8/7/2013)
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 215 % -62.5%
Quick Ratio 11.3 % -0.35%
Debt-to-equity 91.6 % +281%
Return On Equity -200 % -119%
Return On Assets -104 % -41.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.67M shares +65.5%
Common Stock, Shares, Outstanding 5.71M shares +42.5%
Entity Public Float 19M USD -40.8%
Common Stock, Value, Issued 57.1K USD +42.5%
Weighted Average Number of Shares Outstanding, Basic 4.66M shares +16.7%
Weighted Average Number of Shares Outstanding, Diluted 4.66M shares +16.7%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 188K USD -41.2%
Selling and Marketing Expense 1.74M USD +9.66%
General and Administrative Expense 9.15M USD -19.5%
Operating Income (Loss) -14.1M USD +27.8%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -14M USD +27.3%
Earnings Per Share, Basic -3.36 USD/shares +31.6%
Earnings Per Share, Diluted -0.05 USD/shares +37.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.33M USD -63.9%
Accounts Receivable, after Allowance for Credit Loss, Current 387K USD -10.2%
Inventory, Net 568K USD +44.3%
Assets, Current 6.88M USD -56.9%
Property, Plant and Equipment, Net 910K USD -41.2%
Operating Lease, Right-of-Use Asset 2.43M USD -19.1%
Intangible Assets, Net (Excluding Goodwill) 239K USD -10.3%
Goodwill 0 USD -100%
Other Assets, Noncurrent 121K USD -30.4%
Assets 10.6M USD -49.5%
Accounts Payable, Current 1.56M USD +54.2%
Accrued Liabilities, Current 1.95M USD +18%
Contract with Customer, Liability, Current 270K USD -57%
Liabilities, Current 4.62M USD +22.7%
Operating Lease, Liability, Noncurrent 1.86M USD -25.5%
Other Liabilities, Noncurrent 13.7K USD
Liabilities 6.49M USD +3.69%
Retained Earnings (Accumulated Deficit) -175M USD -8.71%
Stockholders' Equity Attributable to Parent 4.09M USD -72.2%
Liabilities and Equity 10.6M USD -49.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.42M USD +0.34%
Net Cash Provided by (Used in) Financing Activities -112K USD
Net Cash Provided by (Used in) Investing Activities -3.03K USD +93.5%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.53M USD -1.64%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.74K USD
Deferred Tax Assets, Valuation Allowance 24.5M USD -69.7%
Deferred Tax Assets, Gross 25.2M USD -68.8%
Operating Lease, Liability 2.42M USD -18.3%
Depreciation 621K USD -27.8%
Payments to Acquire Property, Plant, and Equipment 3.03K USD -87.6%
Lessee, Operating Lease, Liability, to be Paid 3M USD -22.6%
Property, Plant and Equipment, Gross 4.76M USD -1.35%
Operating Lease, Liability, Current 562K USD +20.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 804K USD -6.29%
Lessee, Operating Lease, Liability, to be Paid, Year One 858K USD -3.36%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 581K USD -36.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 828K USD +3.01%
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 139K USD -83.2%
Additional Paid in Capital 179M USD +1.94%
Amortization of Intangible Assets 27.5K USD -87.6%
Depreciation, Depletion and Amortization 163K USD -31.7%
Share-based Payment Arrangement, Expense -6.52K USD -108%